Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: A post hoc analysis of EXCEED

被引：0
|
作者：
Kaeley, Gurjit S. [1 ]
Schett, Georg [2 ,3 ]
Conaghan, Philip G. [4 ,5 ]
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Friedrich Alexander Univ Erlangen Nuremberg, Erlangen, Germany
[3] Univ Klinikum Erlangen, Erlangen, Germany
[4] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[5] Leeds Teaching Hosp NHS Trust, Natl Inst Hlth Res Leeds Biomed Res Ctr, Leeds, W Yorkshire, England
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
32956
引用
收藏
页码：AB54 / AB54
页数：1
相关论文
共 50 条
  • [1] ENTHESITIS IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH SECUKINUMAB OR ADALIMUMAB: A POST HOC ANALYSIS OF EXCEED
    Kaeley, G. S.
    Schett, G.
    Conaghan, P. G.
    Mcgonagle, D.
    Behrens, F.
    Goupille, P.
    Gaillez, C.
    Parikh, B.
    Meng, X.
    Bakewell, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 311 - 312
  • [2] Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study
    Kaeley, Gurjit S.
    Schett, Georg
    Conaghan, Philip G.
    McGonagle, Dennis
    Behrens, Frank
    Goupille, Philippe
    Gaillez, Corine
    Parikh, Bhumik
    Bakewell, Catherine
    [J]. RHEUMATOLOGY, 2024, 63 (01): : 41 - 49
  • [3] Secukinumab for enthesitis in psoriatic arthritis
    Thorley, Jennifer
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (01): : E11 - E11
  • [4] Secukinumab versus adalimumab for psoriatic arthritis
    Thorley, Jennifer
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (06): : E322 - E322
  • [5] Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis
    Wu, Ping
    Huang, Chunlin
    Liao, Pei-Fen
    Ruperto, Nicolino
    Zeng, Huasong
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (11) : 2119 - 2121
  • [6] Efficacy of secukinumab and adalimumab in psoriatic arthritis patients with moderate-to-severe plaque psoriasis: Results from the EXCEED study
    Gottlieb, Alice B.
    Merola, Joseph F.
    Reich, Kristian
    Behrens, Frank
    Nash, Peter
    Bao, Weibin
    Pellet, Pascale
    Pricop, Luminita
    McInnes, Iain B.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB92 - AB92
  • [7] Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial
    Baraliakos, Xenofon
    Pournara, Effie
    Gossec, Laure
    Mease, Philip J.
    White, Roisin
    O'Brien, Eamonn
    Schulz, Barbara
    Marzo-Ortega, Helena
    Coates, Laura C.
    [J]. RMD OPEN, 2022, 8 (02):
  • [8] Effects of upadacitinib on enthesitis in patients with psoriatic arthritis: a post hoc analysis of SELECT-PsA 1 and 2 trials
    Cantini, Fabrizio
    Marchesoni, Antonio
    Novelli, Lucia
    Gualberti, Giuliana
    Marando, Francesca
    McDearmon-Blondell, Erin L.
    Gao, Tianming
    McGonagle, Dennis
    Salvarani, Carlo
    [J]. RHEUMATOLOGY, 2024,
  • [9] Secukinumab in the Treatment of Dactylitis in Patients with Psoriatic Arthritis: Post Hoc Analysis Results from a Randomized Phase 3 Trial
    Kirkham, Bruce
    Nash, Peter
    Navarra, Sandra
    Quebe-Fehling, Erhard
    Gaillez, Corine
    Sastre, Carlos
    Mease, Philip
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [10] Joint-specific Responses to Tofacitinib and Adalimumab in Patients with Psoriatic Arthritis: Post Hoc Analysis of a Phase 3 Study
    Ciurea, Adrian
    Killeen, Tim
    Micheroli, Raphael
    Gassman, Norina N.
    Jo, Hyejin
    Kwok, Kenneth
    Kudlacz, Elizabeth
    Distler, Oliver
    Ospelt, Caroline
    Frank-Bertoncelj, Mojca
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2811 - 2814
12345